EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 12 industry peers in the Health Care Technology industry. EQS gets an excellent profitability rating and is at the same time showing great financial health properties. EQS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
EQS had a positive operating cash flow in the past year.
Each year in the past 5 years EQS has been profitable.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.45%, EQS belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.87%, EQS belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
EQS's Return On Invested Capital of 14.93% is amongst the best of the industry. EQS outperforms 92.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 9.17%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROIC | 14.93% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
1.3 Margins
With an excellent Profit Margin value of 19.64%, EQS belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
EQS's Profit Margin has improved in the last couple of years.
EQS has a Operating Margin of 22.49%. This is amongst the best in the industry. EQS outperforms 84.62% of its industry peers.
In the last couple of years the Operating Margin of EQS has remained more or less at the same level.
EQS's Gross Margin of 68.63% is on the low side compared to the rest of the industry. EQS is outperformed by 61.54% of its industry peers.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% |
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
Compared to 1 year ago, EQS has more shares outstanding
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
EQS has an Altman-Z score of 3.60. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EQS (3.60) is better than 76.92% of its industry peers.
EQS has a debt to FCF ratio of 1.67. This is a very positive value and a sign of high solvency as it would only need 1.67 years to pay back of all of its debts.
EQS has a better Debt to FCF ratio (1.67) than 69.23% of its industry peers.
EQS has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
EQS has a Debt to Equity ratio of 0.15. This is in the better half of the industry: EQS outperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Altman-Z | 3.6 |
ROIC/WACC1.94
WACC7.7%
2.3 Liquidity
EQS has a Current Ratio of 1.09. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EQS (1.09) is comparable to the rest of the industry.
A Quick Ratio of 1.00 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Quick ratio (1.00) which is comparable to the rest of the industry.
EQS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.99%.
EQS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.04% yearly.
Looking at the last year, EQS shows a decrease in Revenue. The Revenue has decreased by -3.56% in the last year.
Measured over the past years, EQS shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
3.2 Future
The Earnings Per Share is expected to grow by 0.67% on average over the next years.
The Revenue is expected to grow by 5.58% on average over the next years.
EPS Next Y-27.4%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.48, which indicates a correct valuation of EQS.
Based on the Price/Earnings ratio, EQS is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
EQS is valuated rather cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.79, the valuation of EQS can be described as correct.
Based on the Price/Forward Earnings ratio, EQS is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
EQS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.48 | ||
| Fwd PE | 13.79 |
4.2 Price Multiples
76.92% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.17 | ||
| EV/EBITDA | 8.92 |
4.3 Compensation for Growth
EQS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.11
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.23%, EQS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.03, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
5.2 History
On average, the dividend of EQS grows each year by 8.96%, which is quite nice.
Dividend Growth(5Y)8.96%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
EQS pays out 44.47% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP44.47%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPA:EQS (5/2/2025, 7:00:00 PM)
40.25
+1.5 (+3.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap610.59M
Analysts76.67
Price Target60.69 (50.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
Yearly Dividend1.15
Dividend Growth(5Y)8.96%
DP44.47%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.57%
PT rev (3m)-14.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.48 | ||
| Fwd PE | 13.79 | ||
| P/S | 2.84 | ||
| P/FCF | 20.17 | ||
| P/OCF | 12.43 | ||
| P/B | 2.87 | ||
| P/tB | 8.98 | ||
| EV/EBITDA | 8.92 |
EPS(TTM)2.78
EY6.91%
EPS(NY)2.92
Fwd EY7.25%
FCF(TTM)2
FCFY4.96%
OCF(TTM)3.24
OCFY8.05%
SpS14.18
BVpS14.02
TBVpS4.48
PEG (NY)N/A
PEG (5Y)1.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROCE | 17.39% | ||
| ROIC | 14.93% | ||
| ROICexc | 19.32% | ||
| ROICexgc | 59.06% | ||
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% | ||
| FCFM | 14.07% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
ROICexc(3y)23.8%
ROICexc(5y)24.68%
ROICexgc(3y)70.74%
ROICexgc(5y)71.14%
ROCE(3y)20.83%
ROCE(5y)21.18%
ROICexcg growth 3Y-16.59%
ROICexcg growth 5Y-12.82%
ROICexc growth 3Y-7.85%
ROICexc growth 5Y-8.24%
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Debt/EBITDA | 0.51 | ||
| Cap/Depr | 130.21% | ||
| Cap/Sales | 8.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.14% | ||
| Profit Quality | 71.64% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.6 |
F-Score5
WACC7.7%
ROIC/WACC1.94
Cap/Depr(3y)98.83%
Cap/Depr(5y)145.04%
Cap/Sales(3y)6.18%
Cap/Sales(5y)8.15%
Profit Quality(3y)93.06%
Profit Quality(5y)90.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
EPS Next Y-27.4%
EPS Next 2Y-3.86%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
EBIT growth 1Y-15.41%
EBIT growth 3Y6.19%
EBIT growth 5Y7.25%
EBIT Next Year-5.14%
EBIT Next 3Y14.95%
EBIT Next 5YN/A
FCF growth 1Y-27.84%
FCF growth 3Y12.59%
FCF growth 5Y17.34%
OCF growth 1Y-3.3%
OCF growth 3Y6.93%
OCF growth 5Y14.97%